BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20709904)

  • 1. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.
    Gunay-Aygun M; Zivony-Elboum Y; Gumruk F; Geiger D; Cetin M; Khayat M; Kleta R; Kfir N; Anikster Y; Chezar J; Arcos-Burgos M; Shalata A; Stanescu H; Manaster J; Arat M; Edwards H; Freiberg AS; Hart PS; Riney LC; Patzel K; Tanpaiboon P; Markello T; Huizing M; Maric I; Horne M; Kehrel BE; Jurk K; Hansen NF; Cherukuri PF; Jones M; Cruz P; Mullikin JC; Nurden A; White JG; Gahl WA; Falik-Zaccai T
    Blood; 2010 Dec; 116(23):4990-5001. PubMed ID: 20709904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly.
    Fabbro S; Kahr WH; Hinckley J; Wang K; Moseley J; Ryu GY; Nixon B; White JG; Bair T; Schutte B; Di Paola J
    Blood; 2011 Mar; 117(12):3430-4. PubMed ID: 21263149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NBEAL2 mutations and bleeding in patients with gray platelet syndrome.
    Pluthero FG; Di Paola J; Carcao MD; Kahr WHA
    Platelets; 2018 Sep; 29(6):632-635. PubMed ID: 29869935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenias due to gray platelet syndrome or THC2 mutations.
    Di Paola J; Johnson J
    Semin Thromb Hemost; 2011 Sep; 37(6):690-7. PubMed ID: 22102272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray Platelet Syndrome Presenting With Pancytopenia, Splenomegaly, and Bone Marrow Fibrosis.
    Tariq H; Perez Botero J; Higgins RA; Medina EA
    Am J Clin Pathol; 2021 Jul; 156(2):253-258. PubMed ID: 33586768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nonsense NBEAL2 gene mutation causing severe bleeding in a patient with gray platelet syndrome.
    Cao L; Su J; Li J; Yu Z; Bai X; Wang Z; Xia L; Ruan C
    Platelets; 2018 May; 29(3):288-291. PubMed ID: 28504079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous 8bp Deletion in Nbeal2 Recapitulates the Gray Platelet Syndrome in Mice.
    Tomberg K; Khoriaty R; Westrick RJ; Fairfield HE; Reinholdt LG; Brodsky GL; Davizon-Castillo P; Ginsburg D; Di Paola J
    PLoS One; 2016; 11(3):e0150852. PubMed ID: 26950939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of Severe Myelofibrosis, Impaired Platelet Functions and Abnormalities in a Patient with Gray Platelet Syndrome Successfully Treated by Stem Cell Transplantation.
    Favier R; Roussel X; Audia S; Bordet JC; De Maistre E; Hirsch P; Neuhart A; Bedgedjian I; Gkalea V; Favier M; Daguindau E; Nurden P; Deconinck E
    Platelets; 2020 May; 31(4):536-540. PubMed ID: 31502501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray Platelet Syndrome-Unusual Presentation with Spontaneous Splenic Rupture: A Case Report and Literature Review.
    Barghouthi DI; Abu-Hilal LH; Njoum Y; Hasan AD; Alshawwa K; Hourani F
    J Investig Med High Impact Case Rep; 2023; 11():23247096231196697. PubMed ID: 37649376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency.
    Bottega R; Pecci A; De Candia E; Pujol-Moix N; Heller PG; Noris P; De Rocco D; Podda GM; Glembotsky AC; Cattaneo M; Balduini CL; Savoia A
    Haematologica; 2013 Jun; 98(6):868-74. PubMed ID: 23100277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.
    Di Buduo CA; Alberelli MA; Glembostky AC; Podda G; Lev PR; Cattaneo M; Landolfi R; Heller PG; Balduini A; De Candia E
    Sci Rep; 2016 Mar; 6():23213. PubMed ID: 26987485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.
    Sims MC; Mayer L; Collins JH; Bariana TK; Megy K; Lavenu-Bombled C; Seyres D; Kollipara L; Burden FS; Greene D; Lee D; Rodriguez-Romera A; Alessi MC; Astle WJ; Bahou WF; Bury L; Chalmers E; Da Silva R; De Candia E; Deevi SVV; Farrow S; Gomez K; Grassi L; Greinacher A; Gresele P; Hart D; Hurtaud MF; Kelly AM; Kerr R; Le Quellec S; Leblanc T; Leinøe EB; Mapeta R; McKinney H; Michelson AD; Morais S; Nugent D; Papadia S; Park SJ; Pasi J; Podda GM; Poon MC; Reed R; Sekhar M; Shalev H; Sivapalaratnam S; Steinberg-Shemer O; Stephens JC; Tait RC; Turro E; Wu JKM; Zieger B; ; Kuijpers TW; Whetton AD; Sickmann A; Freson K; Downes K; Erber WN; Frontini M; Nurden P; Ouwehand WH; Favier R; Guerrero JA
    Blood; 2020 Oct; 136(17):1956-1967. PubMed ID: 32693407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome.
    Albers CA; Cvejic A; Favier R; Bouwmans EE; Alessi MC; Bertone P; Jordan G; Kettleborough RN; Kiddle G; Kostadima M; Read RJ; Sipos B; Sivapalaratnam S; Smethurst PA; Stephens J; Voss K; Nurden A; Rendon A; Nurden P; Ouwehand WH
    Nat Genet; 2011 Jul; 43(8):735-7. PubMed ID: 21765411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome.
    Savoia A; Balduini CL; Savino M; Noris P; Del Vecchio M; Perrotta S; Belletti S; Poggi ; Iolascon A
    Blood; 2001 Mar; 97(5):1330-5. PubMed ID: 11222377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil specific granule and NETosis defects in gray platelet syndrome.
    Aarts CEM; Downes K; Hoogendijk AJ; Sprenkeler EGG; Gazendam RP; Favier R; Favier M; Tool ATJ; van Hamme JL; Kostadima MA; Waller K; Zieger B; van Bergen MGJM; Langemeijer SMC; van der Reijden BA; Janssen H; van den Berg TK; van Bruggen R; Meijer AB; Ouwehand WH; Kuijpers TW
    Blood Adv; 2021 Jan; 5(2):549-564. PubMed ID: 33496751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules.
    Gunay-Aygun M; Falik-Zaccai TC; Vilboux T; Zivony-Elboum Y; Gumruk F; Cetin M; Khayat M; Boerkoel CF; Kfir N; Huang Y; Maynard D; Dorward H; Berger K; Kleta R; Anikster Y; Arat M; Freiberg AS; Kehrel BE; Jurk K; Cruz P; Mullikin JC; White JG; Huizing M; Gahl WA
    Nat Genet; 2011 Jul; 43(8):732-4. PubMed ID: 21765412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet proteome and function in X-linked thrombocytopenia with thalassemia and
    Bergemalm D; Ramström S; Kardeby C; Hultenby K; Eremo AG; Sihlbom C; Bergström J; Palmblad J; Åström M
    Haematologica; 2021 Nov; 106(11):2947-2959. PubMed ID: 33054111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune dysregulation, autoimmunity, and granule defects in gray platelet syndrome.
    Collins JH; Mayer L; Guerrero Lopez JA
    J Thromb Haemost; 2023 Jun; 21(6):1409-1419. PubMed ID: 37028650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.
    Larocca LM; Heller PG; Podda G; Pujol-Moix N; Glembotsky AC; Pecci A; Alberelli MA; Balduini CL; Landolfi R; Cattaneo M; De Candia E
    Platelets; 2015; 26(8):751-7. PubMed ID: 25806575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful hematopoietic engraftment with gray platelets after allogeneic hematopoietic stem cell transplantation from gray platelet syndrome donor.
    Katgi A; Ataca P; Kahraman S; Sevindik OG; Sonmez U; Solmaz SM; Piskin O; Demirkan F; Ozsan GH
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):208-10. PubMed ID: 23358204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.